1. Home
  2. AL vs GRFS Comparison

AL vs GRFS Comparison

Compare AL & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air Lease Corporation

AL

Air Lease Corporation

N/A

Current Price

$64.63

Market Cap

7.3B

ML Signal

N/A

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$7.99

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AL
GRFS
Founded
2010
1940
Country
United States
Spain
Employees
160
25247
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
5.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AL
GRFS
Price
$64.63
$7.99
Analyst Decision
Buy
Hold
Analyst Count
3
2
Target Price
$66.67
$10.15
AVG Volume (30 Days)
2.1M
647.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.36%
1.77%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.98
$5.33
Revenue Next Year
$5.32
$6.50
P/E Ratio
$6.97
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$38.25
$6.19
52 Week High
$64.97
$11.14

Technical Indicators

Market Signals
Indicator
AL
GRFS
Relative Strength Index (RSI) 48.23 29.52
Support Level $63.44 $7.64
Resistance Level $64.97 $9.85
Average True Range (ATR) 0.13 0.30
MACD -0.03 -0.12
Stochastic Oscillator 25.56 8.19

Price Performance

Historical Comparison
AL
GRFS

About AL Air Lease Corporation

Air Lease Corp is an aircraft leasing company based in the United States. It is engaged in the modern, fuel-efficient new technology commercial jet aircraft directly from aircraft manufacturers and leasing those aircraft to airlines throughout the world to generate attractive returns on equity. The company also sells aircraft from its fleet to third parties, including other leasing companies, financial services companies, airlines, and other investors, and offers fleet management services to investors and owners of aircraft portfolios for a management fee. Geographically, it derives a maximum of its revenue from the Europe and the rest from Asia Pacific, Middle East and Africa, Central America, South America, Mexico, the United States, and Canada.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: